{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:57:14Z","timestamp":1792202234026,"version":"4.4.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Guidelines on the treatment of oesophageal squamous cell carcinoma (SCC) recommend neoadjuvant chemoradiotherapy plus surgery or definitive chemoradiotherapy. The aim of this study was to evaluate the outcome of patients with a cCR after chemoradiotherapy who underwent active surveillance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with oesophageal SCC who were treated with chemoradiotherapy between January 2016 and June 2022 were identified from an institutional database. Survival and recurrence of patients with a cCR who underwent active surveillance were compared with those of patients who underwent planned surgery. Survival was calculated according to the Kaplan\u2013Meier method and compared between groups using the log rank test.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 37 patients who underwent active surveillance were older and tumours were more often located in the middle\/upper-third of the oesophagus than in the surgery group of 57 patients. Median follow-up was 28.1 (i.q.r. 17.2\u201347.1) months for the active surveillance group and 20 (12.9\u201339.1) months for the surgery group. Overall survival was comparable between the two groups, with 3-year survival rates of 50 (95% c.i. 31 to 67) and 59 (40 to 73)% for the active surveillance and surgery groups respectively (P = 0.55). Three-year progression-free survival for patients who underwent active surveillance was better than in the surgery group: 70 (43 to 85) versus 58 (40 to 72)% (P = 0.02). Overall and progression-free survival was comparable between patients in the active surveillance group and 23 patients in the surgery group who had a pCR (ypT0 N0). The overall recurrence rate was comparable between the groups: 7 of 37 (19.4%) in active surveillance group versus 16 of 49 (32.6%) in surgery group (P = 0.26). Locoregional recurrence was noted more often in the active surveillance group and systemic recurrence in the surgery group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Active surveillance is feasible and safe for patients with oesophageal SCC who have a cCR after chemoradiotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjs\/znae036","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T22:46:06Z","timestamp":1709073966000},"source":"Crossref","is-referenced-by-count":11,"title":["Active surveillance for clinical complete responders after chemoradiotherapy for oesophageal squamous cell carcinoma"],"prefix":"10.1093","volume":"111","author":[{"given":"Carlo A","family":"De Pasqual","sequence":"first","affiliation":[{"name":"Department of General and Upper Gastrointestinal Surgery, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9859-6038","authenticated-orcid":false,"given":"Jacopo","family":"Weindelmayer","sequence":"additional","affiliation":[{"name":"Department of General and Upper Gastrointestinal Surgery, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Gervasi","sequence":"additional","affiliation":[{"name":"Department of General and Upper Gastrointestinal Surgery, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Torroni","sequence":"additional","affiliation":[{"name":"Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pavarana","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cenzi","sequence":"additional","affiliation":[{"name":"Department of Radiology, OCM Hospital of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Togliani","sequence":"additional","affiliation":[{"name":"Gastroenterology and Digestive Endoscopy Unit, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rossi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giacopuzzi","sequence":"additional","affiliation":[{"name":"Department of General and Upper Gastrointestinal Surgery, University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"2024022721543723900_znae036-B1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","article-title":"The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020","volume":"163","author":"Morgan","year":"2022","journal-title":"Gastroenterology"},{"key":"2024022721543723900_znae036-B2","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"2024022721543723900_znae036-B3","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.3390\/cancers12123614","article-title":"Long-term outcomes of induction chemotherapy followed by chemo-radiotherapy as intensive neoadjuvant protocol in patients with esophageal cancer","volume":"12","author":"Simoni","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2024022721543723900_znae036-B4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.1997.15.1.277","article-title":"Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study","volume":"15","author":"al-Sarraf","year":"1997","journal-title":"J Clin Oncol"},{"key":"2024022721543723900_znae036-B5","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"key":"2024022721543723900_znae036-B6","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"2024022721543723900_znae036-B7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s11605-013-2269-3","article-title":"Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?","volume":"17","author":"Castoro","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"2024022721543723900_znae036-B8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/1759-7714.12874","article-title":"Clinical complete response after chemoradiotherapy for carcinoma of thoracic esophagus: is esophagectomy always necessary? A systematic review and meta-analysis","volume":"9","author":"Wang","year":"2018","journal-title":"Thorac Cancer"},{"key":"2024022721543723900_znae036-B9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/SLA.0000000000000228","article-title":"Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case\u2013control study","volume":"258","author":"Piessen","year":"2013","journal-title":"Ann Surg"},{"key":"2024022721543723900_znae036-B10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1","year":"2022","journal-title":"Ann Oncol"},{"key":"2024022721543723900_znae036-B11","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.20.00866","article-title":"Treatment of locally advanced esophageal carcinoma: ASCO guideline","volume":"38","author":"Shah","year":"2020","journal-title":"J Clin Oncol"},{"key":"2024022721543723900_znae036-B12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1470-2045(18)30201-8","article-title":"Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study","volume":"19","author":"Noordman","year":"2018","journal-title":"Lancet Oncol"},{"key":"2024022721543723900_znae036-B13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13063-021-05274-w","article-title":"Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer","volume":"22","author":"Eyck","year":"2021","journal-title":"Trials"},{"key":"2024022721543723900_znae036-B14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12885-020-6669-y","article-title":"Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"2024022721543723900_znae036-B15","doi-asserted-by":"crossref","first-page":"917961","DOI":"10.3389\/fonc.2022.917961","article-title":"Neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed: the study protocol for the randomized controlled NEEDS trial","volume":"12","author":"Nilsson","year":"2022","journal-title":"Front Oncol"},{"key":"2024022721543723900_znae036-B16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.21037\/acs.2017.03.14","article-title":"8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice","volume":"6","author":"Rice","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"2024022721543723900_znae036-B17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"2024022721543723900_znae036-B18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SLA.0000000000001098","article-title":"International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG)","volume":"262","author":"Low","year":"2015","journal-title":"Ann Surg"},{"key":"2024022721543723900_znae036-B19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien\u2013Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"2024022721543723900_znae036-B20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/PAS.0b013e31821a5692","article-title":"How to define a positive circumferential resection margin in T3 adenocarcinoma of the esophagus","volume":"35","author":"Verhage","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"2024022721543723900_znae036-B21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/annonc\/mds617","article-title":"Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort","volume":"24","author":"Cheedella","year":"2013","journal-title":"Ann Oncol"},{"key":"2024022721543723900_znae036-B22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/SLA.0000000000003636","article-title":"Active surveillance versus immediate surgery in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal cancer: a multicenter propensity matched study","volume":"274","author":"van der Wilk","year":"2021","journal-title":"Ann Surg"},{"key":"2024022721543723900_znae036-B23","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1097\/SLA.0000000000003858","article-title":"Comment on \u2018Active surveillance versus immediate surgery in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal cancer\u2019","volume":"274","author":"Molena","year":"2021","journal-title":"Ann Surg"},{"key":"2024022721543723900_znae036-B24","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jtho.2019.04.004","article-title":"Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: a diagnostic systematic review and meta-analysis","volume":"14","author":"de Gouw","year":"2019","journal-title":"J Thorac Oncol"},{"key":"2024022721543723900_znae036-B25","first-page":"CD010511","article-title":"Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer","author":"Vellayappan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2024022721543723900_znae036-B26","doi-asserted-by":"crossref","first-page":"znad352","DOI":"10.1093\/bjs\/znad352","article-title":"Patient choice of surgery or surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal carcinoma","volume":"111","author":"Walsh","year":"2024","journal-title":"Br J Surg"},{"key":"2024022721543723900_znae036-B27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jjco\/hyx040","article-title":"Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical stage II\/III esophageal squamous cell carcinoma (JCOG1406-A)","volume":"47","author":"Nomura","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"2024022721543723900_znae036-B28","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jtcvs.2018.01.086","article-title":"Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma","volume":"155","author":"Barbetta","year":"2018","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/111\/2\/znae036\/56773427\/znae036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/111\/2\/znae036\/56773427\/znae036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T22:46:15Z","timestamp":1709073975000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/doi\/10.1093\/bjs\/znae036\/7615111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,27]]},"published-print":{"date-parts":[[2024,1,31]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znae036","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,1,31]]},"article-number":"znae036"}}